Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xtant Medical

Xtant Medical
$2.51 SHARE PRICE (As of Friday Closing)

Xtant Medical Holdings Inc mainly develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The company operates through the single segment of Development, manufacture, and marketing of regenerative medical products and devices. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants, and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders and others.

Formerly Known As
Bacterin International
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
Primary Office
  • 664 Cruiser Lane
  • Belgrade, MT 59714
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xtant Medical’s full profile, request a free trial.

Xtant Medical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.61 - $4.88 $33M $2.42 -$4.91 2.92K 13.2M

Xtant Medical Financials Summary

In Thousands,
FY 2018
FY 2017
FY 2016
Enterprise Value 108,139 92,815 145,703 135,720
Revenue 67,525 72,203 82,612 90,003
EBITDA (52,517) (53,364) (29,297) 61
Net Income (64,582) (70,099) (52,411) (19,494)
Total Assets 44,497 46,422 105,705 144,102
Total Debt 76,491 78,569 138,952 130,747
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Xtant Medical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
Debt Status

This information is reserved for PitchBook Platform users. To explore Xtant Medical‘s full profile, request access.

Request full access to PitchBook

Xtant Medical Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Misonix Corporation Farmingdale, NY 000
000000 000000 Corporation Warsaw, IN 00000 00.000 000000000 00.000
00000000 Corporation Carlsbad, CA 000 00000000. 00
000000 0000000 Formerly VC-backed Audubon, PA 0000 00000 00000000000 00000
000000000 Corporation Minneapolis, MN 00000 00000000
To view this company’s complete list of competitors, request access »

Xtant Medical Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0-00000 0000000 31-Jul-2015 000000000000000000 000.00 Therapeutic Devices 000000 0000000000
00000000 0000000 18-Jul-2011 000000000000000000 000 Surgical Devices 000 0000
Ace Oil & Gas 24-Oct-2007 Merger/Acquisition Energy Exploration
To view this company’s complete investment and acquisition history, request access »

Xtant Medical Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Xtant Medical‘s full profile, request access.

Request full access to PitchBook

Xtant Medical Executive Team (18)

Name Title Board
Darrel Holmes Co-Chief Operating Officer
Kevin Brandt Executive & Senior Vice President
Molly Mason Vice President, Business Development and Contract Administration
Jimmy Bornheimer Vice President, Finance
Steve Smith Vice President, Regulatory and Quality Assurance

12 Former Executives

You’re viewing 5 of 18 executives. Get the full list »

Xtant Medical Board Members (11)

Name Representing Role Since Contact
0000 00000000 Xtant Medical Board Member 000 0000
0000 00000000 Self Board Member 000 0000
0000 000000 Self Board Member 000 0000

8 Former Board Members

You’re viewing 3 of 11 board members. Get the full list »